Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Edmond M. Linossi is active.

Publication


Featured researches published by Edmond M. Linossi.


Cytokine & Growth Factor Reviews | 2013

Suppression of cytokine signaling: the SOCS perspective.

Edmond M. Linossi; Jeffrey J. Babon; Douglas J. Hilton; Sandra E. Nicholson

The discovery of the Suppressor of Cytokine Signaling (SOCS) family of proteins has resulted in a significant body of research dedicated to dissecting their biological functions and the molecular mechanisms by which they achieve potent and specific inhibition of cytokine and growth factor signaling. The Australian contribution to this field has been substantial, with the initial discovery of SOCS1 by Hilton, Starr and colleagues (discovered concurrently by two other groups) and the following work, providing a new perspective on the regulation of JAK/STAT signaling. In this review, we reflect on the critical discoveries that have lead to our current understanding of how SOCS proteins function and discuss what we see as important questions for future research.


Nature Immunology | 2016

CIS is a potent checkpoint in NK cell–mediated tumor immunity

Rebecca B. Delconte; Tatiana B. Kolesnik; Laura F. Dagley; Jai Rautela; Wei Shi; Eva M. Putz; Kimberley Stannard; Jian Guo Zhang; Charis E. Teh; Matt Firth; Takashi Ushiki; Christopher E. Andoniou; Mariapia A. Degli-Esposti; Phillip P Sharp; C.E. Sanvitale; Giuseppe Infusini; Nicholas P. D. Liau; Edmond M. Linossi; Christopher J. Burns; Sebastian Carotta; Daniel Gray; Cyril Seillet; Dana S. Hutchinson; Gabrielle T. Belz; Andrew I. Webb; Warren S. Alexander; Shawn S.-C. Li; Alex N. Bullock; Jeffery J. Babon; Mark J. Smyth

The detection of aberrant cells by natural killer (NK) cells is controlled by the integration of signals from activating and inhibitory ligands and from cytokines such as IL-15. We identified cytokine-inducible SH2-containing protein (CIS, encoded by Cish) as a critical negative regulator of IL-15 signaling in NK cells. Cish was rapidly induced in response to IL-15, and deletion of Cish rendered NK cells hypersensitive to IL-15, as evidenced by enhanced proliferation, survival, IFN-γ production and cytotoxicity toward tumors. This was associated with increased JAK-STAT signaling in NK cells in which Cish was deleted. Correspondingly, CIS interacted with the tyrosine kinase JAK1, inhibiting its enzymatic activity and targeting JAK for proteasomal degradation. Cish−/− mice were resistant to melanoma, prostate and breast cancer metastasis in vivo, and this was intrinsic to NK cell activity. Our data uncover a potent intracellular checkpoint in NK cell–mediated tumor immunity and suggest possibilities for new cancer immunotherapies directed at blocking CIS function.


Iubmb Life | 2012

The socs box—adapting proteins for ubiquitination and proteasomal degradation

Edmond M. Linossi; Sandra E. Nicholson

The suppressor of cytokine signalling (SOCS) box was first identified in the SH2‐containing SOCS box family (cytokine‐inducible SH2‐containing protein, SOCS1–7) and is a 40‐amino acid motif, which functions to recruit an E3 ubiquitin ligase complex consisting of the adapter proteins elongins B and C, Rbx2 and the scaffold protein Cullin5. The SOCS box is found in a diverse array of intracellular signalling molecules, many of which contain different protein interaction domains such as SPRY and WD40 domains, leucine and ankyrin repeats or other functional domains such as GTPases. In general, the SOCS box‐containing proteins are thought to act as substrate‐recognition modules to mediate the polyubiquitination and subsequent degradation of substrate proteins by the 26S proteasome.


PLOS ONE | 2013

Suppressor of Cytokine Signaling (SOCS) 5 utilises distinct domains for regulation of JAK1 and interaction with the adaptor protein Shc-1.

Edmond M. Linossi; Indu R. Chandrashekaran; Tatiana B. Kolesnik; James M. Murphy; Andrew I. Webb; Tracy A. Willson; Lukasz Kedzierski; Alex N. Bullock; Jeffrey J. Babon; Raymond S. Norton; Nicos A. Nicola; Sandra E. Nicholson

Suppressor of Cytokine Signaling (SOCS)5 is thought to act as a tumour suppressor through negative regulation of JAK/STAT and epidermal growth factor (EGF) signaling. However, the mechanism/s by which SOCS5 acts on these two distinct pathways is unclear. We show for the first time that SOCS5 can interact directly with JAK via a unique, conserved region in its N-terminus, which we have termed the JAK interaction region (JIR). Co-expression of SOCS5 was able to specifically reduce JAK1 and JAK2 (but not JAK3 or TYK2) autophosphorylation and this function required both the conserved JIR and additional sequences within the long SOCS5 N-terminal region. We further demonstrate that SOCS5 can directly inhibit JAK1 kinase activity, although its mechanism of action appears distinct from that of SOCS1 and SOCS3. In addition, we identify phosphoTyr317 in Shc-1 as a high-affinity substrate for the SOCS5-SH2 domain and suggest that SOCS5 may negatively regulate EGF and growth factor-driven Shc-1 signaling by binding to this site. These findings suggest that different domains in SOCS5 contribute to two distinct mechanisms for regulation of cytokine and growth factor signaling.


Immunological Reviews | 2015

Kinase inhibition, competitive binding and proteasomal degradation: resolving the molecular function of the suppressor of cytokine signaling (SOCS) proteins.

Edmond M. Linossi; Sandra E. Nicholson

The suppressor of cytokine signaling (SOCS) family of proteins are key negative regulators of cytokine and growth factor signaling. They act at the receptor complex to modulate the intracellular signaling cascade, preventing excessive signaling and restoring homeostasis. This regulation is critical to the normal cessation of signaling, highlighted by the complex inflammatory phenotypes exhibited by mice deficient in SOCS1 or SOCS3. These two SOCS proteins remain the best characterized of the eight family members (CIS, SOCS1‐7), and in particular, we now possess a sound understanding of the mechanism of action for SOCS3. Here, we review the mechanistic role of the SOCS proteins and identify examples where clear, definitive data have been generated and discuss areas where the information is less clear. From this functional viewpoint, we discuss how the SOCS proteins achieve exquisite and specific regulation of cytokine signaling and highlight outstanding questions regarding the function of the less well‐studied SOCS family members.


PLOS Pathogens | 2014

Suppressor of Cytokine Signaling 4 (SOCS4) Protects against Severe Cytokine Storm and Enhances Viral Clearance during Influenza Infection

Lukasz Kedzierski; Edmond M. Linossi; Tatiana B. Kolesnik; E. Bridie Day; Nicola L. Bird; Benjamin T. Kile; Gabrielle T. Belz; Donald Metcalf; Nicos A. Nicola; Katherine Kedzierska; Sandra E. Nicholson

Suppressor of cytokine signaling (SOCS) proteins are key regulators of innate and adaptive immunity. There is no described biological role for SOCS4, despite broad expression in the hematopoietic system. We demonstrate that mice lacking functional SOCS4 protein rapidly succumb to infection with a pathogenic H1N1 influenza virus (PR8) and are hypersusceptible to infection with the less virulent H3N2 (X31) strain. In SOCS4-deficient animals, this led to substantially greater weight loss, dysregulated pro-inflammatory cytokine and chemokine production in the lungs and delayed viral clearance. This was associated with impaired trafficking of influenza-specific CD8 T cells to the site of infection and linked to defects in T cell receptor activation. These results demonstrate that SOCS4 is a critical regulator of anti-viral immunity.


eLife | 2017

Suppressor of cytokine signaling (SOCS)5 ameliorates influenza infection via inhibition of EGFR signaling

Lukasz Kedzierski; Michelle D. Tate; Alan C Hsu; Tatiana B. Kolesnik; Edmond M. Linossi; Laura F. Dagley; Zhaoguang Dong; Sarah Freeman; Giuseppe Infusini; Malcolm R. Starkey; Nicola L. Bird; Simon M. Chatfield; Jeffrey J. Babon; Nicholas D. Huntington; Gabrielle T. Belz; Andrew I. Webb; Peter Wark; Nicos A. Nicola; Jianqing Xu; Katherine Kedzierska; Philip M. Hansbro; Sandra E. Nicholson

Influenza virus infections have a significant impact on global human health. Individuals with suppressed immunity, or suffering from chronic inflammatory conditions such as COPD, are particularly susceptible to influenza. Here we show that suppressor of cytokine signaling (SOCS) five has a pivotal role in restricting influenza A virus in the airway epithelium, through the regulation of epidermal growth factor receptor (EGFR). Socs5-deficient mice exhibit heightened disease severity, with increased viral titres and weight loss. Socs5 levels were differentially regulated in response to distinct influenza viruses (H1N1, H3N2, H5N1 and H11N9) and were reduced in primary epithelial cells from COPD patients, again correlating with increased susceptibility to influenza. Importantly, restoration of SOCS5 levels restricted influenza virus infection, suggesting that manipulating SOCS5 expression and/or SOCS5 targets might be a novel therapeutic approach to influenza. DOI: http://dx.doi.org/10.7554/eLife.20444.001


Arthritis & Rheumatism | 2014

Key Role of Suppressor of Cytokine Signaling 3 in Regulating gp130 Cytokine–Induced Signaling and Limiting Chondrocyte Responses During Murine Inflammatory Arthritis

Xiao Liu; Ben A. Croker; Ian K. Campbell; Stephanie J. Gauci; Warren S. Alexander; Brett A. Tonkin; Nicole C. Walsh; Edmond M. Linossi; Sandra E. Nicholson; Kate E. Lawlor; Ian P. Wicks

To examine the impact of the gp130 cytokine family on murine articular cartilage and to explore a potential regulatory role of suppressor of cytokine signaling 3 (SOCS‐3) in murine chondrocytes.


Cerebral Cortex | 2015

Cortical Layer Inversion and Deregulation of Reelin Signaling in the Absence of SOCS6 and SOCS7.

Isobel D. Lawrenson; Danielle L. Krebs; Edmond M. Linossi; Jian-Guo Zhang; Tamara Mclennan; Caitlin Collin; Helen M. McRae; Tatiana B. Kolesnik; Katrina Koh; Joanne M. Britto; Andrew J. Kueh; Bilal N. Sheikh; Farrah El-Saafin; Nicos A. Nicola; Seong-Seng Tan; Jeffrey J. Babon; Sandra E. Nicholson; Warren S. Alexander; Tim Thomas; Anne K. Voss

Abstract Mutations of the reelin gene cause severe defects in cerebral cortex development and profound intellectual impairment. While many aspects of the reelin signaling pathway have been identified, the molecular and ultimate cellular consequences of reelin signaling remain unknown. Specifically, it is unclear if termination of reelin signaling is as important for normal cortical neuron migration as activation of reelin signaling. Using mice that are single or double deficient, we discovered that combined loss of the suppressors of cytokine signaling, SOCS6 and SOCS7, recapitulated the cortical layer inversion seen in mice lacking reelin and led to a dramatic increase in the reelin signaling molecule disabled (DAB1) in the cortex. The SRC homology domains of SOCS6 and SOCS7 bound DAB1 ex vivo. Mutation of DAB1 greatly diminished binding and protected from degradation by SOCS6. Phosphorylated DAB1 was elevated in cortical neurons in the absence of SOCS6 and SOCS7. Thus, constitutive activation of reelin signaling was observed to be equally detrimental as lack of activation. We hypothesize that, by terminating reelin signaling, SOCS6 and SOCS7 may allow new cycles of reelin signaling to occur and that these may be essential for cortical neuron migration.


Biochemistry | 2015

Structure and Functional Characterization of the Conserved JAK Interaction Region in the Intrinsically Disordered N-Terminus of SOCS5.

Indu R. Chandrashekaran; Biswaranjan Mohanty; Edmond M. Linossi; Laura F. Dagley; Eleanor W. W. Leung; James M. Murphy; Jeffrey J. Babon; Sandra E. Nicholson; Raymond S. Norton

SOCS5 can negatively regulate both JAK/STAT and EGF-receptor pathways and has therefore been implicated in regulating both the immune response and tumorigenesis. Understanding the molecular basis for SOCS5 activity may reveal novel ways to target key components of these signaling pathways. The N-terminal region of SOCS5 coordinates critical protein interactions involved in inhibition of JAK/STAT signaling, and a conserved region within the N-terminus of SOCS5 mediates direct binding to the JAK kinase domain. Here we have characterized the solution conformation of this conserved JAK interaction region (JIR) within the largely disordered N-terminus of SOCS5. Using nuclear magnetic resonance (NMR) chemical shift analysis, relaxation measurements, and NOE analysis, we demonstrate the presence of preformed structural elements in the JIR of mouse SOCS5 (mSOCS5175-244), consisting of an α-helix encompassing residues 224-233, preceded by a turn and an extended structure. We have identified a phosphorylation site (Ser211) within the JIR of mSOCS5 and have investigated the role of phosphorylation in modulating JAK binding using site-directed mutagenesis.

Collaboration


Dive into the Edmond M. Linossi's collaboration.

Top Co-Authors

Avatar

Sandra E. Nicholson

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Jeffrey J. Babon

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Nicos A. Nicola

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Tatiana B. Kolesnik

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Laura F. Dagley

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Andrew I. Webb

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Gabrielle T. Belz

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Jian-Guo Zhang

Walter and Eliza Hall Institute of Medical Research

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge